Screener
NeoGenomics NEO Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Deferred income tax liabilities, net | (1,395) | (1,534) |
| Accrued compensation | 8,685 | (14,340) |
| Accounts payable and other liabilities | (4,085) | 7,718 |
| Net cash provided by (used in) operating activities | 11,822 | (4,997) |
| CASH FLOWS FROM INVESTING ACTIVITIES | ||
| Proceeds from maturities of marketable securities | — | 11,060 |
| Purchases of property and equipment | (13,219) | (10,823) |
| Business acquisition, net of cash acquired | — | (5,991) |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's operating cash flow?
- NeoGenomics (NEO) reported operating cash flow of $19.96M in Q2 2026.
- How has NeoGenomics's operating cash flow changed year-over-year?
- NeoGenomics's operating cash flow decreased by 1.8% year-over-year, from $20.33M to $19.96M.
- What is the long-term trend for NeoGenomics's operating cash flow?
- Over 2 years (2021 to 2025), NeoGenomics's operating cash flow has grown at a -55.8% compound annual growth rate (CAGR), from -$26.72M to $5.23M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about NeoGenomics's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude